Circulating thymus- and activation-regulated chemokine/CCL17 is a useful biomarker for discriminating acute eosinophilic pneumonia from other causes of acute lung injury

Chest

Volumn 131, Issue 6, 2007, Pages 1726-1734

  Miyazaki, Eishi ^a   Nureki, Shin Ichi ^a   Ono, Emiko ^a   Ando, Masaru ^a   Matsuno, Osamu ^a   Fukami, Tetsujiro ^a   Ueno, Takuya ^a   Kumamoto, Toshihide ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Acute eosinophilic pneumonia; Acute lung injury; KL 6; Serum biomarker; Thymus and activation regulated chemokine

Indexed keywords

BIOLOGICAL MARKER; EOTAXIN; SURFACTANT PROTEIN D; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ACUTE LUNG INJURY; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; LOEFFLER PNEUMONIA; LUNG HEMORRHAGE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; THYMUS;

EID: 34250885169     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.06-2596     Document Type: Article

References (35)

1. Allen JN, Pacht ER, Gadek JE, et al. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. N Engl J Med 1989; 321:569-574
2. Badesch DB, King TE, Schwarz MI. Acute eosinophilic pneumonia: a hypersensitivity phenomenon? Am Rev Respir Dis 1989; 139:249-252
3. Allen J. Acute eosinophilic pneumonia. Semin Respir Crit Care Med 2006; 27:142-147
4. Nakajima M, Manabe T, Niki Y, et al. Cigarette smoke-induced acute eosinophilic pneumonia. Radiology 1998; 207:715-719
5. Rom WN, Weiden M, Garcia R, et al. Acute eosinophilic pneumonia in a New York City firefighter exposed to World Trade Center dust. Am J Respir Crit Care Med 2002; 166:797-800
6. Miyazaki E, Sugisaki K, Shigenaga T, et al. A case of acute eosinophilic pneumonia caused by inhalation of Trichosporon terrestre. Am J Respir Crit Care Med 1995; 151:541-543
7. Solomon J, Schwarz M. Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia. Semin Respir Crit Care Med 2006; 27:192-197
8. Shorr AF, Scoville SL, Cersovsky SB, et al. Acute eosinophilic pneumonia among US military personnel deployed in or near Iraq. JAMA 2004; 292:2997-3005
9. Giacoppe GN, Degler DA. Rapidly evolving adult respiratory distress syndrome with eosinophilia of unknown cause in previously healthy active duty soldiers at an Army training center: report of two cases. Mil Med 1999; 164:911-916
10. Weng TI, Yuan A, Tsai KC, et al. A patient of adult respiratory distress syndrome presenting initially with peripheral infiltration on chest radiographs and pulmonary eosinophilia. Am J Emerg Med 2001; 19:457-460
11. Katzenstein AL, Myers JL, Mazur MT. A clinicopathologic, ultrastructual, and cell kinetic study. Am J Surg Pathol 1986; 10:256-267
12. Tazelaar HD, Linz LJ, Colby TV, et al. Acute eosinophilic pneumonia: histopathologic findings in nine patients. Am J Respir Crit Care Med 1997; 155:296-302
13. Katoh S, Matsumoto N, Fukushima K, et al. Elevated chemokine levels in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia. J Allergy Clin Immunol 2000; 106:730-736
14. Miyazaki E, Nureki S, Fukami T, et al. Elevated levels of thymus- and activation-regulated chemokine in bronchoalveolar lavage fluid from patients with eosinophilic pneumonia. Am J Respir Crit Care Med 2002; 165:1125-1131
15. Katoh S, Fukushima K, Matsumoto N, et al. Accumulation of CCR4-expressing CD4+ T cells and high concentration of its ligands (TARC and MDC) in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia. Allergy 2003; 58:518-523
16. Jahnz-Rozyk K, Targowski T, Paluchowska E, et al. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy 2005; 60:685-688
17. Kakinuma T, Nakamura K, Wakugawa M, et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001; 107:535-541
18. Sekiya T, Yamada H, Yamaguchi M, et al. Increased levels of a TH2-type CC chemokine thymus- and activation-regulated chemokine (TARC) in serum and induced sputum of asthmatics. Allergy 2002; 57:173-177
19. Leung TF, Wong CK, Lam CWK, et al. Plasma TARC concentration may be a useful marker for asthmatic exacerbation in children. Eur Respir J 2003; 21:616-629
20. Kohno N, Awaya Y, Oyama T, et al. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease. Am Rev Respir Dis 1993; 148:637-642
21. Honda Y, Kuroki Y, Matsuura E, et al. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am J Respir Crit Care Med 1995; 152:1860-1866
22. Greene KE, Wright JR, Steinberg KP, et al. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med 1999; 160:1843-1850
23. Ishizaka A, Matsuda T, Albertine KH, et al. Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2004; 2S6:L1088-1094
24. Daimon T, Tajima S, Oshikawa K, et al. KL-6 and surfactant proteins A and D in serum and bronchoalveolar lavage fluid in patients with acute eosinophilic pneumonia. Intern Med 2005; 44:811-817
25. Philit F, Etienne-Mastroianni B, Parrot A, et al. Idiopathic acute eosinophilic pneumonia: a study of 22 patients. Am J Respir Crit Care Med 2002; 166:1235-1239
26. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818-824
27. De Lassence A, Fleury-Feith J, Escudier E, et al. Alveolar hemorrhage: diagnostic criteria and results in 194 immunocompromised hosts. Am J Respir Crit Care Med 1995; 151:157-163
28. Pope-Harman AL, Davis WB, Christoforidis AJ, et al. Acute eosinophilic pneumonia: a summary of fifteen cases and review of the literature. Medicine 1996; 75:334-342
29. Nureki S, Miyazaki E, Ando M, et al. CC chemokine receptor 4 ligand production by bronchoalveolar lavage fluid cells in cigarette-smoke-associated acute eosinophilic pneumonia. Clin Immunol 2005; 116:83-93
30. Sekiya T, Miyamasu M, Imanishi M, et al. Inducible expression of a Th2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells. J Immunol 2000; 165:2205-2213
31. Lilly CM, Nakamura H, Belostotsky OI, et al. Eotaxin expression after segmental allergen challenge in subjects with atopic asthma. Am J Respir Crit Care Med 2001; 163:1669-1675
32. Olmishi H, Yokoyama A, Kondo K, et al. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Respir Crit Care Med 2002; 165:378-381
33. Yokoyama A, Kohno N, Hamada H, et al. Circulating KL-6 predicts the: outcome of rapidly progressive idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 158:1680-1684
34. King MA, Pope-Harman A, Allen JN, et al. Acute eosinophilic pneumonia: radiologic and clinical features. Radiology 1997; 203:715-719
35. Tomiyama N, Müller NL, Johkoh T, et al. Acute parenchymal lung disease in immunocompetent patients: diagnostic accuracy of high-resolution CT. Am J Roentgenol 2000; 174:1745-1750